Health Equity Data Access Program (HEDAP)
ID: 355646Type: Forecasted
Overview

Buyer

Centers for Medicare & Medicaid Services (HHS-CMS)

Award Range

$0 - $90K

Eligible Applicants

Private Institutions of Higher Education

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355646
Timeline
    Description

    The Centers for Medicare & Medicaid Services (CMS) is forecasting the Health Equity Data Access Program (HEDAP), which aims to provide funding for six individual user "seats" in the CMS Virtual Research Data Center (VRDC). This program is designed to support researchers conducting health services research focused on health disparities among various underserved populations, including racial and ethnic minorities, individuals with disabilities, and those affected by poverty or inequality. The initiative emphasizes innovative research methods utilizing CMS data to identify and evaluate health disparities, ultimately aiding CMS and its partners in their efforts to eradicate these disparities. Interested applicants, specifically private institutions of higher education, can expect an award ceiling of $90,000 for a funding period of 36 months, with applications due in the fiscal year 2025. For further inquiries, applicants may contact HEResearch@cms.hhs.gov.

    Point(s) of Contact
    HEResearch@cms.hhs.gov
    HEResearch@cms.hhs.gov
    HEResearch@cms.hhs.gov
    Files
    No associated files provided.
    Similar Opportunities
    FDA OMHHE Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH) (U01) Clinical Trials Optional
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH), which will support cooperative agreements aimed at enhancing minority health and health equity research. This initiative seeks to establish a consortium of multiple recipients who will focus on advancing research, outreach, and communication efforts, while also providing training and mentoring for diverse students, fellows, and researchers. The program is crucial for addressing health disparities and promoting equity in healthcare access and outcomes among racial and ethnic minorities. Interested applicants can apply for a funding amount of $3 million, with an expected six awards to be made, and should contact Terrin Brown at terrin.brown@fda.hhs.gov or 240-402-7610 for further information. The opportunity is set for the fiscal year 2025.
    Research Coordinating Center
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a federal grant opportunity for the establishment of a Research Coordinating Center aimed at enhancing collaboration and providing technical assistance to Maternal and Child Health Bureau (MCHB)-funded research programs. The center will facilitate a continuous learning community, implement cross-site evaluations, and develop tools to translate research findings into practical applications. This initiative is critical for improving health outcomes and ensuring effective use of research in practice. The estimated total program funding is $501,000, with one award expected, and interested applicants can reach out to Jessica DiBari and Maura Maloney at (301) 443-2170 or via email at MCHBCC@hrsa.gov. The synopsis is anticipated to be posted on December 18, 2024, with applications closing on March 18, 2025, and project commencement expected on September 1, 2025.
    PNS: Health Equity
    Administration for Community Living
    The Administration for Community Living is forecasting a grant opportunity titled "PNS: Health Equity," aimed at promoting health equity for individuals with intellectual and developmental disabilities (I/DD) and their families. The project will be funded under the Projects of National Significance within the Developmental Disabilities Assistance and Bill of Rights Act, focusing on creating opportunities for individuals with I/DD to participate fully in community life and supporting the development of policies that enhance their self-determination and inclusion. The grant has an award ceiling of $1 million and a floor of $300,000, with an estimated total program funding of $1 million, and is expected to result in one award. Interested applicants, specifically private institutions of higher education, can find more information and contact Larissa Crossen at larissa.crossen@acl.hhs.gov or (202) 795-7333, with key deadlines including an estimated synopsis close date of April 28, 2023, and an estimated award date of September 1, 2023.
    FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering the Health Equity Innovation Award (U01) to fund innovative research aimed at enhancing minority health and advancing health equity objectives. This funding opportunity focuses on proposals that promote diversity in clinical trials, improve data availability on diverse populations, and amplify the voices of underrepresented patient groups. With an award ceiling of $1 million and a floor of $250,000, the FDA anticipates making four awards in fiscal year 2024. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610 for further information.
    Projects of National Significance: Health Equity
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Health Equity," aimed at enhancing health equity for individuals with intellectual and developmental disabilities (I/DD) and their families. This initiative, supported under the Developmental Disabilities Assistance and Bill of Rights Act, seeks to create opportunities for these individuals to engage fully in community life and to influence national and state policies that promote their self-determination and inclusion. The program anticipates awarding five cooperative agreements, with funding amounts ranging from $300,000 to $375,000, totaling an estimated $1,875,000 for the fiscal year 2024. Interested applicants, particularly private institutions of higher education and eligible faith-based organizations, should note that the estimated synopsis post date is March 29, 2024, with applications closing on May 28, 2024; for further inquiries, contact Larissa Crossen at (202) 795-7333 or via email at larissa.crossen@acl.hhs.gov.
    Projects of National Significance: Health Equity
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Health Equity," aimed at enhancing health equity for individuals with intellectual and developmental disabilities (I/DD) and their families. This initiative, supported under the Developmental Disabilities Assistance and Bill of Rights Act, seeks to create opportunities for these individuals to engage fully in community life and to influence national and state policies that promote their self-determination and inclusion. The program anticipates awarding five cooperative agreements, with funding amounts ranging from $300,000 to $375,000, totaling an estimated $1,875,000 for the fiscal year 2025. Interested applicants, particularly private institutions of higher education and eligible faith-based organizations, should contact Larissa Crossen at (202) 795-7333 or via email at larissa.crossen@acl.hhs.gov for further details, with proposals expected to be submitted by July 30, 2025.
    FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01)," aimed at advancing minority health and health equity objectives. This cooperative agreement seeks innovative research proposals that enhance diversity in clinical trials, improve data availability on diverse populations, and amplify diverse patient perspectives and needs. The initiative is crucial for addressing disparities in health outcomes and ensuring equitable representation in health research. Interested applicants can apply for a funding amount of $1 million, with an expected four awards to be made, and should direct inquiries to Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610. The opportunity is set for the fiscal year 2025 and was last updated on August 14, 2024.
    Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety
    Centers for Disease Control - NCEZID
    The Centers for Disease Control - NCEZID is offering a federal grant opportunity titled "Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety." This initiative aims to establish a collaborative network among healthcare systems, facilities, and public health partners to enhance the detection, response, and prevention of threats to patient and healthcare worker safety, ultimately improving the quality and resilience of U.S. healthcare delivery. The program is particularly relevant for various healthcare settings, including hospitals, nursing homes, and outpatient facilities, and encourages partnerships with public health departments and relevant entities. Interested applicants can apply for funding ranging from $2.5 million to $15 million, with an estimated total program funding of $750 million and an expected ten awards. Applications must be submitted electronically by June 5, 2026, with the anticipated award date set for August 1, 2026. For further inquiries, applicants may contact Carla Doan at gon5@cdc.gov or by phone at 770-488-8354.
    Hereditary Hemorrhagic Telangiectasia (HHT) Center
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Hereditary Hemorrhagic Telangiectasia (HHT) Center," aimed at reducing morbidity and mortality associated with HHT. The program's objectives include expanding access to care for HHT patients and developing a de-identified patient data registry to enhance understanding of this rare disease and its treatment outcomes. This cooperative agreement is crucial for improving health outcomes for affected individuals and is open to various domestic public or private entities, including faith-based organizations. The estimated total program funding is $2,000,000, with one award expected, and interested applicants should note that the synopsis is anticipated to be posted on January 10, 2025, with a closing date of April 11, 2025. For further inquiries, applicants can contact Nordia Williams at (240) 475-3310 or via email at Nwilliams1@hrsa.gov.
    Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Health and Health Care Disparities Among Persons Living with Disabilities" (R01 - Clinical Trials Optional) aimed at supporting innovative research that addresses the health challenges faced by individuals with disabilities, particularly in relation to race, ethnicity, and socio-economic status. The initiative seeks to investigate the systemic factors that adversely affect the health and well-being of this population, with a focus on understanding barriers to healthcare access and developing effective interventions to mitigate disparities. This funding opportunity is crucial for enhancing healthcare outcomes for marginalized groups living with disabilities through collaborative, community-engaged research. Interested applicants can apply for grants with an award ceiling of $500,000, and the application process opened on January 5, 2024, with a submission deadline of November 5, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-309.html.